Government & Public Affairs Roundtable

The T2B Government & Public Affairs Roundtable connects biopharma communicators at the intersection of policy, politics, public perception, and trust. This roundtable fosters collaboration among professionals across dedicated government affairs roles and broader communications functions to explore how strategic engagement with policymakers, coalitions, and the public shapes market access, strengthens reputation, supports innovation, and drives long-term success globally.

Roundtable objectives

  • Foster peer exchange on anticipating and adapting to political dynamics, policy priorities, the geopolitical environment, and evolving regulatory dynamics.
  • Demonstrate the strategic value of government and public affairs across organizational stages.
  • Examine the role of communicators in building trust and authentic engagement with policymakers, coalitions, and the public.
  • Equip the T2B community with practical resources and insights to elevate government affairs as a strategic function aligned with corporate affairs, executive communications, market access, and reputation management.
Chair
Bret Coons

Bret Coons

Head of Global Issues Communications

Takeda

Roundtable members

Dan Gaynor

Dan Gaynor

Executive Fellow

Harvard Business School

Meredith Isola

Meredith Isola

Managing Director, Healthcare

Narrative Strategies

Miriam Kalnicki

Miriam Kalnicki

Deputy Head, Corp. Affairs Practice & Head, Reputation & Risk Management

Syneos Health Communications

Lee McGuire

Lee McGuire

Chief Communications & Government Relations Officer

Broad Institute

Michael Pratt

Michael Pratt

Chief Communications Officer

National Pharmaceutical Council

Chief of Staff / PM
Myles Goldman

Myles Goldman

Principal & Manager

Boston Health Communications

“Ensuring that we can effectively represent, and advocate for, the vital work of the life sciences industry and the needs of patients has rarely been more important than it is today. It is my sincere hope that this roundtable can build a solid foundation for demonstrating and exploring how Communications and Government Affairs colleagues can come together to meet the challenges and opportunities of the current environment.”

Bret Coons

Head of Global Issues Communications, Takeda Pharmaceutical Company Limited

Interested in joining this roundtable?

Why join

  • Connect policy, politics, and public trust. Exchange perspectives with peers working across government affairs, public affairs, corporate communications, advocacy, market access, and reputation management.

  • Pressure-test real-world challenges. Explore how biopharma communicators can anticipate and respond to shifting policy priorities, regulatory dynamics, geopolitical issues, and public perception challenges.

  • Build stronger cross-functional alignment. Share practical ideas for how communications and government affairs teams can work together to engage policymakers, coalitions, patients, and the public with greater clarity and impact.

Eligibility requirements

Applicants must have:

  • Experience in government affairs, public affairs, policy, advocacy, or related communications work in the biopharma, healthcare, or life sciences sector.
  • A strong interest in helping biopharma communicators better understand the strategic role of government and public affairs across organizational stages.
  • The ability to volunteer 3–5 hours/month to co-create quarterly Government & Public Affairs Roundtable events and monthly resources for the broader T2B community.
  • Willingness to participate in regular roundtable team meetings and contribute ideas, perspective, and feedback.
  • An active T2B Pro membership.

Apply for a spot on the Government & Public Affairs Roundtable

Applications are closed and will reopen in August 2027. Each member term is for one calendar year.